Research report: Ambrisentan ameliorates methotrexate nephrotoxicity through modulation of RhoA/ROCK and PI3K/MDM2-associated signaling: network pharmacology-guided discovery and in vivo confirmation
A rat study found that the pulmonary hypertension drug ambrisentan, given before and during methotrexate exposure, protected the kidneys by ...
